Tuberculosis Vaccine Market Report

Europe Tuberculosis Vaccine Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 12, 2019
  • PAGES：207
  • REPORT CODE：GMM315564
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Tuberculosis Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 9.8% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Tuberculosis Vaccine Market Segmentations:

    By Player:

    • Beijing Tiantan Biological Products

    • GSK

    • Shanghai Institute of Biological Products

    • Sanofi-Pasteur

    • Chengdu Institute of Biological Products

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Tuberculosis Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Tuberculosis Vaccine Market Size and Growth Rate of Type 1 from 2014 to 2026

    • 1.3.2 Europe Tuberculosis Vaccine Market Size and Growth Rate of Type 2 from 2014 to 2026

    • 1.3.3 Europe Tuberculosis Vaccine Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Tuberculosis Vaccine Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • 1.4.2 Europe Tuberculosis Vaccine Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • 1.4.3 Europe Tuberculosis Vaccine Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Tuberculosis Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Tuberculosis Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3

    4 Segmentation of Tuberculosis Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Tuberculosis Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Tuberculosis Vaccine for End-Users 1

      • 4.4.2 Market Size and Growth Rate of Tuberculosis Vaccine for End-Users 2

      • 4.4.3 Market Size and Growth Rate of Tuberculosis Vaccine for End-Users 3

    5 Market Analysis by Major Regions

    • 5.1 Europe Tuberculosis Vaccine Production Analysis by Top Regions

    • 5.2 Europe Tuberculosis Vaccine Consumption Analysis by Top Regions

    • 5.3 Europe Tuberculosis Vaccine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.3 France Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Tuberculosis Vaccine Market among Top Countries

    • 6.1 Top 5 Export Countries in Tuberculosis Vaccine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Tuberculosis Vaccine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Tuberculosis Vaccine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Tuberculosis Vaccine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Tuberculosis Vaccine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Tuberculosis Vaccine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Tuberculosis Vaccine Landscape Analysis

    • 7.1 Germany Tuberculosis Vaccine Landscape Analysis by Major Types

    • 7.2 Germany Tuberculosis Vaccine Landscape Analysis by Major End-Users

    8. UK Tuberculosis Vaccine Landscape Analysis

    • 8.1 UK Tuberculosis Vaccine Landscape Analysis by Major Types

    • 8.2 UK Tuberculosis Vaccine Landscape Analysis by Major End-Users

    9. France Tuberculosis Vaccine Landscape Analysis

    • 9.1 France Tuberculosis Vaccine Landscape Analysis by Major Types

    • 9.2 France Tuberculosis Vaccine Landscape Analysis by Major End-Users

    10. Italy Tuberculosis Vaccine Landscape Analysis

    • 10.1 Italy Tuberculosis Vaccine Landscape Analysis by Major Types

    • 10.2 Italy Tuberculosis Vaccine Landscape Analysis by Major End-Users

    11. Spain Tuberculosis Vaccine Landscape Analysis

    • 11.1 Spain Tuberculosis Vaccine Landscape Analysis by Major Types

    • 11.2 Spain Tuberculosis Vaccine Landscape Analysis by Major End-Users

    12. Poland Tuberculosis Vaccine Landscape Analysis

    • 12.1 Poland Tuberculosis Vaccine Landscape Analysis by Major Types

    • 12.2 Poland Tuberculosis Vaccine Landscape Analysis by Major End-Users

    13. Russia Tuberculosis Vaccine Landscape Analysis

    • 13.1 Russia Tuberculosis Vaccine Landscape Analysis by Major Types

    • 13.2 Russia Tuberculosis Vaccine Landscape Analysis by Major End-Users

    14. Switzerland Tuberculosis Vaccine Landscape Analysis

    • 14.1 Switzerland Tuberculosis Vaccine Landscape Analysis by Major Types

    • 14.2 Switzerland Tuberculosis Vaccine Landscape Analysis by Major End-Users

    15. Turkey Tuberculosis Vaccine Landscape Analysis

    • 15.1 Turkey Tuberculosis Vaccine Landscape Analysis by Major Types

    • 15.2 Turkey Tuberculosis Vaccine Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis Vaccine Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis Vaccine Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis Vaccine Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis Vaccine Landscape Analysis by Top Countries

      • 16.3.1 Denmark Tuberculosis Vaccine Market Volume and Growth Rate

      • 16.3.2 Finland Tuberculosis Vaccine Market Volume and Growth Rate

      • 16.3.3 Norway Tuberculosis Vaccine Market Volume and Growth Rate

      • 16.3.4 Sweden Tuberculosis Vaccine Market Volume and Growth Rate

      • 16.3.6 Iceland Tuberculosis Vaccine Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis Vaccine Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis Vaccine Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis Vaccine Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis Vaccine Landscape Analysis by Top Countries

      • 17.3.1 Belgium Tuberculosis Vaccine Market Volume and Growth Rate

      • 17.3.2 Netherlands Tuberculosis Vaccine Market Volume and Growth Rate

      • 17.3.3 Luxembourg Tuberculosis Vaccine Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis Vaccine Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis Vaccine Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis Vaccine Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis Vaccine Landscape Analysis by Top Countries

      • 18.3.1 Estonia Tuberculosis Vaccine Market Volume and Growth Rate

      • 18.3.2 Latvia Tuberculosis Vaccine Market Volume and Growth Rate

      • 18.3.3 Lithuania Tuberculosis Vaccine Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Beijing Tiantan Biological Products

      • 19.1.1 Beijing Tiantan Biological Products Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 GSK

      • 19.2.1 GSK Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Shanghai Institute of Biological Products

      • 19.3.1 Shanghai Institute of Biological Products Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Sanofi-Pasteur

      • 19.4.1 Sanofi-Pasteur Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Chengdu Institute of Biological Products

      • 19.5.1 Chengdu Institute of Biological Products Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    The List of Tables and Figures (Totals 65 Figures and 117 Tables)

    • Figure Product Picture

    • Figure Europe Tuberculosis Vaccine Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Europe Tuberculosis Vaccine Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Europe Tuberculosis Vaccine Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Europe Tuberculosis Vaccine Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • Figure Europe Tuberculosis Vaccine Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • Figure Europe Tuberculosis Vaccine Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • Figure Germany Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure France Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Tuberculosis Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Tuberculosis Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Tuberculosis Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Tuberculosis Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of Tuberculosis Vaccine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Tuberculosis Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Tuberculosis Vaccine by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of End-User 1

    • Figure Market Size and Growth Rate of End-User 2

    • Figure Market Size and Growth Rate of End-User 3

    • Table Europe Tuberculosis Vaccine Production by Major Regions

    • Table Europe Tuberculosis Vaccine Production Share by Major Regions

    • Figure Europe Tuberculosis Vaccine Production Share by Major Countries and Regions in 2014

    • Table Europe Tuberculosis Vaccine Consumption by Major Regions

    • Table Europe Tuberculosis Vaccine Consumption Share by Major Regions

    • Table Germany Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

    • Table UK Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

    • Table France Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

    • Table Italy Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

    • Table Spain Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

    • Table Poland Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

    • Table Russia Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

    • Table Switzerland Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

    • Table Turkey Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis Vaccine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Tuberculosis Vaccine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Tuberculosis Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Tuberculosis Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Tuberculosis Vaccine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Tuberculosis Vaccine Consumption by Types from 2014 to 2026

    • Table Germany Tuberculosis Vaccine Consumption Share by Types from 2014 to 2026

    • Table Germany Tuberculosis Vaccine Consumption by End-Users from 2014 to 2026

    • Table Germany Tuberculosis Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table UK Tuberculosis Vaccine Consumption by Types from 2014 to 2026

    • Table UK Tuberculosis Vaccine Consumption Share by Types from 2014 to 2026

    • Table UK Tuberculosis Vaccine Consumption by End-Users from 2014 to 2026

    • Table UK Tuberculosis Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table France Tuberculosis Vaccine Consumption by Types from 2014 to 2026

    • Table France Tuberculosis Vaccine Consumption Share by Types from 2014 to 2026

    • Table France Tuberculosis Vaccine Consumption by End-Users from 2014 to 2026

    • Table France Tuberculosis Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Italy Tuberculosis Vaccine Consumption by Types from 2014 to 2026

    • Table Italy Tuberculosis Vaccine Consumption Share by Types from 2014 to 2026

    • Table Italy Tuberculosis Vaccine Consumption by End-Users from 2014 to 2026

    • Table Italy Tuberculosis Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Spain Tuberculosis Vaccine Consumption by Types from 2014 to 2026

    • Table Spain Tuberculosis Vaccine Consumption Share by Types from 2014 to 2026

    • Table Spain Tuberculosis Vaccine Consumption by End-Users from 2014 to 2026

    • Table Spain Tuberculosis Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Poland Tuberculosis Vaccine Consumption by Types from 2014 to 2026

    • Table Poland Tuberculosis Vaccine Consumption Share by Types from 2014 to 2026

    • Table Poland Tuberculosis Vaccine Consumption by End-Users from 2014 to 2026

    • Table Poland Tuberculosis Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Russia Tuberculosis Vaccine Consumption by Types from 2014 to 2026

    • Table Russia Tuberculosis Vaccine Consumption Share by Types from 2014 to 2026

    • Table Russia Tuberculosis Vaccine Consumption by End-Users from 2014 to 2026

    • Table Russia Tuberculosis Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Tuberculosis Vaccine Consumption by Types from 2014 to 2026

    • Table Switzerland Tuberculosis Vaccine Consumption Share by Types from 2014 to 2026

    • Table Switzerland Tuberculosis Vaccine Consumption by End-Users from 2014 to 2026

    • Table Switzerland Tuberculosis Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Tuberculosis Vaccine Consumption by Types from 2014 to 2026

    • Table Turkey Tuberculosis Vaccine Consumption Share by Types from 2014 to 2026

    • Table Turkey Tuberculosis Vaccine Consumption by End-Users from 2014 to 2026

    • Table Turkey Tuberculosis Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis Vaccine Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis Vaccine Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis Vaccine Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Tuberculosis Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Tuberculosis Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Tuberculosis Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Tuberculosis Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Tuberculosis Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Tuberculosis Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis Vaccine Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis Vaccine Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis Vaccine Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Tuberculosis Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Tuberculosis Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Tuberculosis Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Tuberculosis Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis Vaccine Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis Vaccine Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis Vaccine Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Tuberculosis Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Tuberculosis Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Tuberculosis Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Tuberculosis Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Beijing Tiantan Biological Products

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Beijing Tiantan Biological Products

    • Figure Sales and Growth Rate Analysis of Beijing Tiantan Biological Products

    • Figure Revenue and Market Share Analysis of Beijing Tiantan Biological Products

    • Table Product and Service Introduction of Beijing Tiantan Biological Products

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Shanghai Institute of Biological Products

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai Institute of Biological Products

    • Figure Sales and Growth Rate Analysis of Shanghai Institute of Biological Products

    • Figure Revenue and Market Share Analysis of Shanghai Institute of Biological Products

    • Table Product and Service Introduction of Shanghai Institute of Biological Products

    • Table Company Profile and Development Status of Sanofi-Pasteur

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Pasteur

    • Figure Sales and Growth Rate Analysis of Sanofi-Pasteur

    • Figure Revenue and Market Share Analysis of Sanofi-Pasteur

    • Table Product and Service Introduction of Sanofi-Pasteur

    • Table Company Profile and Development Status of Chengdu Institute of Biological Products

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chengdu Institute of Biological Products

    • Figure Sales and Growth Rate Analysis of Chengdu Institute of Biological Products

    • Figure Revenue and Market Share Analysis of Chengdu Institute of Biological Products

    • Table Product and Service Introduction of Chengdu Institute of Biological Products

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US